http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008148625-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aac831a6be8de686431c615fcce2d8ae
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
filingDate 2006-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3fd83590270e2db6b2dd137e8d5f92a
publicationDate 2008-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2008148625-A
titleOfInvention Clone ES cell production method
abstract [PROBLEMS] To provide a human ES cell production technology capable of clearing ethical problems and a technology related to the production technology. A nucleus derived from a somatic cell is transplanted to an enucleated unfertilized egg to form a cloned embryo, and the cloned embryo is developed to a split embryo. After that, for example, the blastomere cells of the divided embryos generated up to the 8-cell stage are co-cultured with separately prepared ES cells of the same animal species, so that the cloned ES cells derived from the divided embryos, that is, the blastomere cell-derived clone ES cells. To produce. Thereafter, the clone ES cell is selected and cultured to establish a clone ES cell line. [Selection] Figure 1
priorityDate 2006-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450455866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447544793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22502

Total number of triples: 16.